Agilent Technologies Inc (0HAV.L)

Healthcare | Medical Pharmaceuticals
Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$6.0B

Net Income

$2.5B

Operating Margin

50.7%

Free Cash Flow

$4.2B

Debt / Assets

30.4%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Agilent Technologies Inc (0HAV.L).
Income Statement (Quarterly) 2025-12-31 2025-10-31 2025-09-30 2025-07-31
Revenue 6,032,320,723 1,861,000,000 4,148,000,000 1,738,000,000
Cost of Revenue 2,910,054,064 897,000,000 1,890,000,000 824,000,000
Gross Profit 3,122,266,659 964,000,000 2,258,000,000 914,000,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 0 428,000,000 77,000,000 417,000,000
Operating Expenses 64,983,761 521,000,000 173,000,000 554,000,000
Operating Income 3,057,282,898 443,000,000 2,085,000,000 360,000,000
Interest Expense 102,552,497 27,000,000 99,000,000 28,000,000
Income Before Tax 4,068,592,684 442,000,000 2,381,000,000 366,000,000
Income Tax Expense 806,204,789 8,000,000 477,000,000 30,000,000
Net Income 2,493,405,000 434,000,000 1,302,000,000 336,000,000
Per Share
EPS 1.46 1.53 0.76 1.18
EPS Diluted 0.00 0.00 0.00 0.00